News & Updates
Filter by Specialty:
Intensive BP-lowering a no-go after reperfusion in ischaemic stroke
14 Nov 2022
byRoshini Claire Anthony
An intensive blood pressure target (<120 mm Hg) should be avoided in patients who have undergone endovascular thrombectomy for acute ischaemic stroke (AIS) for large-vessel occlusion (LVO), results of the phase III ENCHANTED2/MT* trial showed.
Intensive BP-lowering a no-go after reperfusion in ischaemic stroke
14 Nov 2022
Rezvilutamide-ADT trumps bicalutamide-ADT for high-volume mHSPC
14 Nov 2022
byAudrey Abella
In the interim analyses of the phase III CHART trial, a combination regimen of ADT* and the novel second-generation androgen-receptor (AR) inhibitor rezvilutamide trumped the bicalutamide-ADT combination in terms of survival outcomes in individuals with high-volume metastatic hormone-sensitive prostate cancer (mHSPC).
